A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)
AstraZeneca
AstraZeneca
Puma Biotechnology, Inc.
Western Regional Medical Center
Washington University School of Medicine
University of Southern California
National Cancer Institute (NCI)
Washington University School of Medicine
National Cancer Institute (NCI)
National Cancer Institute (NCI)